Stevanato Group S.p.A.
NYSE: STVN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Franco Stevanato
- Employees
- 5,521
- Headquarters
- Piombino Dese, Italy
- IPO year
- 2021
- Market cap
- $4.7B
- Website
- https://www.stevanatogroup.com
Loading STVN…
Loading profile data…Frequently asked questions about STVN
What does Stevanato Group S.p.A. (STVN) do?
Stevanato Group S.p.A. is dedicated to engineering, manufacturing, and distributing integrated solutions for the pharmaceutical and healthcare sectors. Its core offerings span a wide array of products, including containment solutions, drug delivery systems, and medical devices, alongside diagnostic and analytical support. The company also produc...
Where does STVN trade?
Stevanato Group S.p.A. (STVN) trades on the New York Stock Exchange.
What sector is STVN in?
Stevanato Group S.p.A. (STVN) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of Stevanato Group S.p.A.?
Franco Stevanato is the chief executive officer of Stevanato Group S.p.A. (STVN).
Where is Stevanato Group S.p.A. headquartered?
Stevanato Group S.p.A. is headquartered in Italy.
Does STVN pay a dividend?
Yes — Stevanato Group S.p.A. (STVN) paid a trailing twelve-month dividend of USD 0.06 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did STVN go public?
Stevanato Group S.p.A. (STVN) completed its initial public offering in 2021.